To prohibit federal Medicaid and CHIP funds for sex-rejecting procedures in minors due to concerns over safety and lack of evidence.
Approach:
Policy Initiative: The HHS, through CMS, enacted a rule to stop federal funding for sex-rejecting procedures for children, citing long-term health risks and insufficient reliable clinical evidence.
Key Findings:
Procedures that reject biological sex in children, such as puberty blockers and cross-sex hormones, may lead to irreversible consequences, including infertility and impaired sexual function.
The review by HHS found significant gaps in evidence and serious safety issues regarding these interventions.
The decision aligns with growing caution within the medical community and references international evaluations.
Interpretation:
The final rule emphasizes the need for reliable evidence in federal healthcare funding decisions, particularly concerning children's health.
Limitations:
The rule only affects federal funding through Medicaid and CHIP, not private insurance or other funding sources.
Mental health services coverage remains unchanged under Medicaid and CHIP.
